Sigilon Therapeutics Inc (SGTX)
22.47 -0.59 (-2.56%) 08/11/23 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,561 | -77,311 | -54,608 | -43,925 | N/A |
| Depreciation Amortization | 1,272 | 1,121 | 854 | 675 | N/A |
| Accounts receivable | -3,399 | 118 | -41 | -136 | N/A |
| Accounts payable and accrued liabilities | -1,236 | 713 | -467 | 164 | N/A |
| Other Working Capital | -19,267 | -13,420 | -15,460 | -10,890 | N/A |
| Other Operating Activity | 14,717 | 10,374 | 8,074 | 4,038 | 0 |
| Operating Cash Flow | $-51,474 | $-78,405 | $-61,648 | $-50,074 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,750 | N/A | N/A | N/A | N/A |
| PPE Investments | -307 | -1,834 | -972 | -1,209 | N/A |
| Purchase Of Investment | -42,524 | -16,226 | N/A | N/A | N/A |
| Investing Cash Flow | $-12,081 | $-18,060 | $-972 | $-1,209 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,788 | 11,000 | N/A |
| Debt Repayment | -1,667 | N/A | -15,000 | -1,000 | N/A |
| Common Stock Issued | 61 | 2,176 | 132,527 | 119 | N/A |
| Other Financing Activity | 0 | -622 | 52,082 | 53,123 | 0 |
| Financing Cash Flow | $-1,606 | $1,554 | $189,397 | $63,242 | $N/A |
| Beginning Cash Position | 108,511 | 203,422 | 76,645 | 64,686 | N/A |
| End Cash Position | 43,350 | 108,511 | 203,422 | 76,645 | N/A |
| Net Cash Flow | $-65,161 | $-94,911 | $126,777 | $11,959 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,474 | -78,405 | -61,648 | -50,074 | N/A |
| Capital Expenditure | -537 | -1,834 | -972 | -1,209 | N/A |
| Free Cash Flow | -52,011 | -80,239 | -62,620 | -51,283 | 0 |